01Purpose and principlesWhat the assessment is for and the core concepts behind it.
Pelvic ultrasound is most useful when the request contains a discriminating question. Include last menstrual period or menopausal status, pregnancy result, bleeding pattern, pain, examination, hormones such as HRT or tamoxifen and previous imaging. The sonographer can then select transabdominal, transvaginal and Doppler components. A generic request for ‘pelvic pain’ risks a technically complete scan that cannot answer ectopic, torsion, bowel or endometriosis questions.
Transabdominal scanning uses a full bladder as an acoustic window and surveys a larger field, which helps with large fibroids, pelvic masses and anatomy extending beyond the transvaginal field. Resolution of endometrium and small adnexal lesions is lower, especially with bowel gas or increased tissue depth. Transvaginal scanning uses a covered internal probe close to pelvic organs, usually with an empty bladder, and gives better endometrial and adnexal detail. It is an intimate procedure requiring explanation, voluntary consent and the option to stop; absence of previous penetrative sex is not an automatic technical prohibition, but patient preference and appropriateness govern.
NICE NG88 makes investigation symptom-led in heavy menstrual bleeding. Offer outpatient hysteroscopy first when history suggests a submucosal fibroid, polyp or endometrial pathology, including persistent intermenstrual bleeding or relevant risk factors. Offer pelvic ultrasound first when the uterus is palpable abdominally, an abdominal or pelvic mass is suspected, or examination is inconclusive or difficult. When adenomyosis is suspected through marked dysmenorrhoea or a bulky tender uterus, transvaginal ultrasound is preferred to transabdominal ultrasound or MRI; explain limitations if the preferred test is declined.
Endometrial thickness must be contextualised. In menstruating patients it changes with cycle phase, anovulation and hormone exposure, so there is no universal reassuring cut-off. Focal lesions, irregularity, vascularity and the clinical pattern matter. For postmenopausal bleeding, transvaginal measurement of the double-layer endometrium helps triage. UK cancer pathways commonly use 4 mm: an endometrium above this or not adequately seen prompts endometrial assessment, while a clearly visualised thinner lining makes cancer less likely. Persistent or recurrent bleeding still warrants re-evaluation because focal disease can be missed.
Hormone therapy alters interpretation. The British Menopause Society joint guidance uses different reassuring thresholds for a fully visualised uniform endometrium in unscheduled bleeding: 4 mm or less with continuous combined HRT and 7 mm or less with sequential HRT, alongside assessment of regimen, timing and cancer risk. These thresholds do not apply indiscriminately to tamoxifen, premenopausal bleeding or a focal lesion. Local urgent pathways and the patient’s risk profile determine whether hysteroscopy and biopsy remain appropriate.
Endometrial histology is the definitive assessment for hyperplasia or cancer, but the route matters. Hysteroscopy directly visualises the cavity and allows targeted biopsy or polyp treatment. NICE advises sampling at hysteroscopy for selected patients at high risk of endometrial pathology, including persistent irregular or intermenstrual bleeding, infrequent heavy bleeding with obesity or polycystic ovary syndrome, tamoxifen use, or unsuccessful treatment; blind biopsy is not recommended in the HMB pathway. An insufficient sample is not negative and requires a plan based on ongoing risk and imaging.
Adnexal imaging requires description rather than the vague term cyst. Report size, laterality, unilocular or multilocular structure, solid parts, papillary projections, septations, vascularity, ascites and comparison with prior scans. Ultrasound can raise or lower malignancy probability but not provide histology. Sudden pain and vomiting require torsion assessment even when arterial flow is present, because dual blood supply and intermittent torsion limit Doppler exclusion. A complex mass or ascites needs specialist triage rather than repeated nonspecific scanning.
Key points
- Name the imaging question before ordering: pregnancy location, endometrium, fibroid mapping, adenomyosis, ovarian mass, torsion, abscess or device position require different timing and interpretation.
- Transvaginal ultrasound usually provides higher-resolution views of endometrium and adnexa; seek specific consent, offer a chaperone and provide a transabdominal or deferred alternative when declined.
- Transabdominal ultrasound gives a wider pelvic overview and can help with large masses or when transvaginal scanning is unsuitable, but a full bladder and lower resolution can limit detail.
- For heavy menstrual bleeding with suspected submucosal fibroid, polyp or endometrial pathology, NICE recommends outpatient hysteroscopy as first-line investigation rather than ultrasound alone.
- For heavy bleeding with a palpable uterus, suspected pelvic mass or difficult examination, NICE recommends pelvic ultrasound as first-line investigation; transvaginal ultrasound is preferred when adenomyosis is suspected.
- In premenopausal patients, endometrial thickness changes across the cycle and no single cut-off excludes hyperplasia or cancer; symptoms, risk factors, focal appearance and histology determine next steps.
- For postmenopausal bleeding, transvaginal endometrial measurement is a triage tool within an urgent pathway. A commonly used 4 mm threshold must follow the applicable cancer protocol, image quality and recurrence history.
- NICE advises endometrial biopsy in the context of hysteroscopy for selected high-risk heavy-bleeding presentations and advises against blind biopsy in that pathway.
- Ultrasound describes morphology, not final histology. Polyps, hyperplasia and cancer can overlap, and an inadequate scan should trigger another diagnostic method rather than a normal label.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Persistent intermenstrual bleeding, irregular bleeding or risk factors for endometrial disease increases the value of direct hysteroscopy and selected biopsy.
Heavy bleeding with substantial dysmenorrhoea or a bulky tender uterus supports transvaginal ultrasound, while a normal scan does not eliminate every case.
Any bleeding after established menopause is abnormal and enters urgent assessment; recurrent bleeding remains important after an initially reassuring thickness.
Solid vascular components, papillary projections, irregular multilocularity, bilateral complex lesions or ascites increases malignant probability and specialist urgency.
Abrupt unilateral pain, vomiting and an adnexal lesion suggest torsion; sonographic enlargement and oedema support it, but preserved flow cannot exclude it.
If the lining is not completely visualised, a reported partial measurement cannot be treated as a reassuring threshold result.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Transvaginal ultrasoundFirst step - Why
- Obtain detailed views of endometrium, myometrium, ovaries, adnexa and early pregnancy.
- Interpretation and limitations
- Consent and image quality are essential. Thickness, focal lesions and morphology are interpreted against cycle, menopause, hormones and symptoms; normal imaging does not exclude all endometriosis or torsion.
- 02
Transabdominal pelvic ultrasound - Why
- Survey large uterine or adnexal disease and provide an alternative or complement to internal scanning.
- Interpretation and limitations
- A full bladder and wider field help orientation, but lower resolution may miss focal cavity or small adnexal disease; state when transvaginal imaging was not performed.
- 03
Outpatient hysteroscopy - Why
- Directly inspect the uterine cavity for polyp, submucosal fibroid or focal endometrial pathology.
- Interpretation and limitations
- NICE gives it first-line priority for selected HMB patterns. A negative high-quality cavity view is more informative for focal lesions than ultrasound, but histology is still needed for cellular diagnosis.
- 04
Endometrial biopsy - Why
- Diagnose hyperplasia, atypia or malignancy through histological examination.
- Interpretation and limitations
- Sample at hysteroscopy for selected high-risk HMB patients under NICE. Insufficient or blind sampling may miss focal disease and needs explicit follow-up.
- 05
Pregnancy test and early-pregnancy ultrasound - Why
- Separate pregnancy-related bleeding or pain from non-pregnant endometrial and adnexal pathways.
- Interpretation and limitations
- Positive hCG changes the diagnostic frame. An empty uterus on one early scan can represent early intrauterine, failed or ectopic pregnancy and requires protocolled follow-up.
- 06
Cancer risk and referral assessment - Why
- Apply urgent pathway criteria for postmenopausal bleeding, suspicious mass or concerning endometrial findings.
- Interpretation and limitations
- NICE recommends suspected-cancer referral for postmenopausal bleeding in people aged 55 and over and consideration below 55; local pathways define imaging and sampling sequence.
04Clinical next stepsHow the result changes management or prompts escalation.
01Heavy bleedingChoose hysteroscopy or ultrasound from the suspected siteFirst stepHeavy menstrual bleeding requires investigation because history or examination suggests structural or endometrial disease.+
- 1Use outpatient hysteroscopy first when persistent intermenstrual bleeding or risk factors suggest a cavity or endometrial lesion, explaining biopsy and treatment possibilities.
- 2Use pelvic ultrasound first for a palpable uterus, suspected pelvic mass or difficult examination, and prefer transvaginal scanning when adenomyosis is suspected.
- 3PreferredAlternativeIf the preferred test is declined, offer an acceptable alternative and explain the particular lesions it may miss before agreeing follow-up.
02Postmenopausal bleedingKeep imaging inside an urgent cancer pathwayBleeding occurs after established menopause, including spotting or blood-stained discharge.+
- 1Examine for vulval, vaginal and cervical sources and refer through the age-appropriate urgent pathway without waiting for recurrent bleeding.
- 2Arrange high-quality transvaginal assessment and interpret thickness, uniformity, focal lesions and visualisation using the applicable protocol rather than an isolated number.
- 3Proceed to hysteroscopy and endometrial sampling when threshold, morphology, inadequate imaging or persistent or recurrent bleeding warrants tissue diagnosis.
03Adnexal massSeparate acute torsion from malignancy triageUltrasound identifies an ovarian or adnexal lesion or symptoms suggest one.+
- 1EscalationEscalate sudden severe pain, vomiting or peritonism for urgent gynaecological assessment; do not let Doppler flow alone defer torsion management.
- 2For a stable lesion, document morphology, size, laterality, menopausal status and relevant markers, then apply the current local or RCOG risk pathway.
- 3Refer complex morphology, solid vascular components, ascites or high-risk clinical features to specialist services instead of repeatedly scanning without ownership.
04Inconclusive testResolve uncertainty with the next modalityThe endometrium, cavity or adnexa is not adequately visualised or sampling is insufficient.+
- 1Check technical limitations, cycle or hormone context and whether the original clinical question remains unanswered.
- 2Select repeat expert ultrasound, hysteroscopy, targeted biopsy or cross-sectional imaging according to the suspected site and urgency.
- 3Do not code an incomplete scan or insufficient biopsy as normal; communicate the residual risk and assign a named follow-up clinician.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Track every postmenopausal bleeding referral, ultrasound, hysteroscopy and histology result to a documented diagnosis or further plan, including inadequate tests.
- For interval-scanned adnexal lesions, record the guideline basis, measurement method, morphology, comparison date and exact trigger for earlier review.
- Reassess persistent or recurrent bleeding despite a thin endometrium, benign biopsy or treatment response because new or focal pathology can emerge or be missed.
- Document transvaginal consent, chaperone arrangements, route actually performed and limitations so later clinicians do not assume a complete pelvic study.
- Escalate worsening unilateral pain, vomiting, heavy bleeding, syncope, fever or a new positive pregnancy test independently of an elective imaging schedule.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Thickness is conditional
An endometrial number only has meaning when the entire lining is seen and menopausal, cycle, HRT and symptom contexts are correctly assigned.
Modality follows location
Ultrasound maps myometrium and adnexa, hysteroscopy sees the cavity, and histology identifies cellular disease; no single test replaces all three functions.
A thin lining is triage
Reduced probability after postmenopausal bleeding is not a lifetime clearance, especially when bleeding persists or a focal lesion was not excluded.
Flow does not untwist
Ovarian dual supply and intermittent twisting mean Doppler flow can persist despite clinically important torsion.
Declining internal scan is valid
Offer transabdominal imaging or another strategy and explain reduced detail; do not frame refusal as forfeiting all diagnostic care.
07Common pitfallsFrequent interpretation and management errors.
- 01
Ordering ultrasound as a universal substitute for hysteroscopy in heavy bleeding with suspected cavity pathology.
- 02
Applying a postmenopausal endometrial threshold to a cycling patient or to a partially visualised lining.
- 03
Reassuring recurrent postmenopausal bleeding solely because the first scan measured a thin endometrium.
- 04
Calling an insufficient endometrial biopsy benign rather than arranging risk-based further assessment.
- 05
Using preserved ovarian Doppler flow to exclude torsion in a patient with a compelling acute presentation.
- 06
Reporting an adnexal cyst without morphology, size, menopausal context or a guideline-based follow-up owner.